The LMD-1530MD is a widescreen HD medical-certified 15-inch* monitor, with a WXGA panel providing 1280 x 768 pixel resolution. The outstanding image quality and lightweight compact design allows for easy integration into a variety of applications, both inside and outside the operating room.
Full HD resolution monitor complies with medical safety standards The LMD-2110MD monitor features a 21.5-inch LCD panel of full HD (1920 x 1080) resolution and 10-bit signal processing. Complying with medical safety standards and EMC standards, the monitor provides a crisp, sharp high definition image
The numerous features and benefits of the LMD-2451MT make it ideal for 3D endoscopic surgery and suited to a wide range of medical settings where critical high-quality 3D monitoring is required. Accommodating multiple input signal formats and interfaces, this monitor offers maximum flexibility and user convenience.
The LMD-2451MD has an advanced 24 inch LCD panel, and has inherited the conventional functions from the formerly introduced LMD-MD series. At full HD resolution WUXGA (1920x 1200) the LMD-2451MD ensures very high quality image representation.
Sony proudly introduces the new standard in visualization …the 27-inch medical monitor*! Design meets technology…the first thing you notice is the monitor’s unique design. The uncommonly slender chassis and front bezel are truly eye catching. Next you’re captivated by the high brightness of the display.
3D imaging is an increasingly important tool in today’s operating rooms. It’s a practical alternative to conventional 2D imaging, giving surgeons a stereoscopic view of high-resolution pictures captured with endoscopes and surgical microscopes. 3D offers an accurate, life-like visual experience, with improved depth perception and spatial orientation. This provides a more realistic visualisation of complex procedures.
The Abbott RealTime CT/NG assay is an in vitro polymerase chain reaction (PCR) assay for the direct, qualitative detection of the plasmid DNA for Chlamydia trachomatis and the genomic DNA of Neisseria gonorrhoeae in female endocervical or vaginal swab specimens, male urethral swab specimens, or male and female urine specimens.
The Abbott RealTime HCV assay is an in vitro reverse transcription-polymerase chain reaction (RT-PCR) assay for the quantitation of hepatitis C viral ribonucleic acid (HCV RNA) in human serum and plasma from HCV-infected individuals.
The Abbott RealTime HCV Genotype II is an in vitro reverse transcription-polymerase chain reaction (RT-PCR) assay for determining the genotype(s) of hepatitis C virus (HCV) in plasma and serum from HCV-infected individuals.
The Abbott RealTime HIV-1 assay is an in vitro reverse transcription-polymerase chain reaction (RT-PCR) assay for the quantitation of Human Immunodeficiency Virus type 1 (HIV-1) on the automated m2000 System in human plasma from HIV-1 infected individuals over the range of 40 to 10,000,000 copies/mL. The Abbott RealTime HIV-1 assay is intended for use in conjunction with clinical presentation and other laboratory markers for disease prognosis and for use as an aid in assessing viral response to antiretroviral treatment as measured by changes in plasma HIV-1 RNA levels.
The Abbott RealTime HIV-1 Qualitative assay aids laboratories and physicians in diagnosing HIV-1 infections in pediatric and adult patients, providing usage of innovative DBS sampling and reliable detection of all HIV-1 groups and subtypes.
The Abbott RealTime MTB RIF/INH Resistance assay is an in vitro polymerase chain reaction (PCR) assay for the qualitative detection of Rifampicin (RIF) and Isoniazid (INH) resistance in MTB positive samples.
3B Scientific® offers adult advanced life support (ALS) manikins and simulators that provide all necessary features for effective advanced life support training for pre-hospital and in-hospital emergencies. They offer realistic features for effective, scenario-based demonstrations, practice and assessments of the core skills needed by healthcare professionals
AneuVysion, which utilizes patented fluorescence in situ hybridization (FISH) technology applied to uncultured amniocytes, provides detection of trisomies 13, 18, and 21 (Down syndrome) and sex chromosome aneusomies in as little as 24 hours.